Literature DB >> 6711571

Characteristics of surviving and nonsurviving patients with primary pulmonary hypertension.

S Rich, P S Levy.   

Abstract

Primary pulmonary hypertension is considered a fatal illness, with survival typically of less than four years, although survival of more than 10 years has been well documented. To assess the characteristics of patients with primary pulmonary hypertension who survive versus those who do not, 12 patients with primary pulmonary hypertension were followed, and their clinical course was documented with serial catheterization. The survivors, four male and three female, had their illness for a mean of 5.2 +/- 2 years from the time of initial catheterization, with six of the seven alive at the end of the follow-up period. The five nonsurvivors, all female, had a mean survival of 0.3 +/- 0.2 years. The nonsurviving group had significantly higher right atrial pressures (17 +/- 6 versus 6 +/- 2 mm Hg), lower cardiac indexes (1.2 +/- 0.1 versus 2.3 +/- 0.5 liters/minute/m2) and stroke volume indexes (12 +/- 7 versus 30 +/- 5 ml/beat/m2), and higher systemic resistances (64 +/- 13 versus 43 +/- 14 units) and pulmonary resistances (57 +/- 31 versus 20 +/- 4 units). The pulmonary artery pressure did not significantly differ between the groups. Using regression analysis, it was found that stroke volume index and right atrial pressure were the best independent predictors of survival, with a coefficient of determination (r2) of 83 and 72, respectively. When the initial and most recent catheterization data were compared among the survivors, no significant differences were found. Determining the stroke volume index and right atrial pressure of patients with primary pulmonary hypertension at the time of their initial presentation should help in predicting their clinical course.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6711571     DOI: 10.1016/0002-9343(84)90279-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Use of noninvasive tools in primary pulmonary hypertension to assess the correlation of right ventricular function with functional capacity and to predict outcome.

Authors:  Nili Zafrir; Boris Zingerman; Alejandro Solodky; Daniel Ben-Dayan; Alex Sagie; Jaqueline Sulkes; Israel Mats; M R Kramer
Journal:  Int J Cardiovasc Imaging       Date:  2006-09-14       Impact factor: 2.357

2.  The treatment of primary pulmonary hypertension.

Authors:  N G Uren; C M Oakley
Journal:  Br Heart J       Date:  1991-08

3.  Percutaneous balloon dilatation of the atrial septum: immediate and midterm results.

Authors:  B D Thanopoulos; D Georgakopoulos; G S Tsaousis; S Simeunovic
Journal:  Heart       Date:  1996-12       Impact factor: 5.994

4.  Clinical correlates of angiographically diagnosed idiopathic pulmonary hypertension.

Authors:  H H Gray; J M Morgan; I H Kerr; G A Miller
Journal:  Thorax       Date:  1990-06       Impact factor: 9.139

5.  Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry.

Authors:  Lynette M Brown; Hubert Chen; Scott Halpern; Darren Taichman; Michael D McGoon; Harrison W Farber; Adaani E Frost; Theodore G Liou; Michelle Turner; Kathy Feldkircher; Dave P Miller; C Gregory Elliott
Journal:  Chest       Date:  2011-03-10       Impact factor: 9.410

Review 6.  Primary pulmonary hypertension. Practical therapeutic recommendations.

Authors:  L J Rubin
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

Review 7.  Pulmonary Hypertension and Indicators of Right Ventricular Function.

Authors:  Célia von Siebenthal; John-David Aubert; Periklis Mitsakis; Patrick Yerly; John O Prior; Laurent Pierre Nicod
Journal:  Front Med (Lausanne)       Date:  2016-06-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.